You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Skin Care Articles
Popular Skin Care Articles
Highly Recommended Skin Care Articles
Send a link to this page to your friends and colleagues.
EMLA, an anesthetic cream made by AstraZeneca of Wilmington, Delaware, has been temporarily removed from the market. The cream is frequently used by insulin pumpers to numb the skin before inserting an infusion set.
Heather Law, from AstraZeneca's public affairs department, said that EMLA will be reintroduced to the market in mid-2003 in child-resistant closure tubes. Until EMLA is reintroduced, it will be available for use in hospitals only. For more information, call the AstraZeneca Information Center at (800) 236-9933.
ELA-Max, an alternative topical anesthetic, is still available. For more information on ELA-Max, call Ferndale Labs at (248) 548-0900.
0 comments - Feb 1, 2003
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.